These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9819383

  • 1. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity.
    Bai RY, Dieter P, Peschel C, Morris SW, Duyster J.
    Mol Cell Biol; 1998 Dec; 18(12):6951-61. PubMed ID: 9819383
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).
    Ouyang T, Bai RY, Bassermann F, von Klitzing C, Klumpen S, Miething C, Morris SW, Peschel C, Duyster J.
    J Biol Chem; 2003 Aug 08; 278(32):30028-36. PubMed ID: 12748172
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions.
    Hegazy SA, Wang P, Anand M, Ingham RJ, Gelebart P, Lai R.
    J Biol Chem; 2010 Jun 25; 285(26):19813-20. PubMed ID: 20424160
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.
    Riera L, Lasorsa E, Ambrogio C, Surrenti N, Voena C, Chiarle R.
    J Biol Chem; 2010 Aug 20; 285(34):26441-50. PubMed ID: 20554525
    [Abstract] [Full Text] [Related]

  • 11. Studies of phosphoproteomic changes induced by nucleophosmin-anaplastic lymphoma kinase (ALK) highlight deregulation of tumor necrosis factor (TNF)/Fas/TNF-related apoptosis-induced ligand signaling pathway in ALK-positive anaplastic large cell lymphoma.
    Wu F, Wang P, Zhang J, Young LC, Lai R, Li L.
    Mol Cell Proteomics; 2010 Jul 20; 9(7):1616-32. PubMed ID: 20393185
    [Abstract] [Full Text] [Related]

  • 12. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis.
    Slupianek A, Nieborowska-Skorska M, Hoser G, Morrione A, Majewski M, Xue L, Morris SW, Wasik MA, Skorski T.
    Cancer Res; 2001 Mar 01; 61(5):2194-9. PubMed ID: 11280786
    [Abstract] [Full Text] [Related]

  • 13. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY, Johnston PB, Burke KA, Zhao Y.
    Cancer Res; 2006 Sep 15; 66(18):9002-8. PubMed ID: 16982741
    [Abstract] [Full Text] [Related]

  • 14. The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation.
    Hübinger G, Scheffrahn I, Müller E, Bai R, Duyster J, Morris SW, Schrezenmeier H, Bergmann L.
    Exp Hematol; 1999 Dec 15; 27(12):1796-805. PubMed ID: 10641597
    [Abstract] [Full Text] [Related]

  • 15. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG.
    Leukemia; 2000 Sep 15; 14(9):1533-59. PubMed ID: 10994999
    [Abstract] [Full Text] [Related]

  • 16. Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.
    Hernández L, Beà S, Bellosillo B, Pinyol M, Falini B, Carbone A, Ott G, Rosenwald A, Fernández A, Pulford K, Mason D, Morris SW, Santos E, Campo E.
    Am J Pathol; 2002 Apr 15; 160(4):1487-94. PubMed ID: 11943732
    [Abstract] [Full Text] [Related]

  • 17. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
    Piccinini G, Bacchiocchi R, Serresi M, Vivani C, Rossetti S, Gennaretti C, Carbonari D, Fazioli F.
    J Biol Chem; 2002 Jun 21; 277(25):22231-9. PubMed ID: 11919185
    [Abstract] [Full Text] [Related]

  • 18. NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.
    Galietta A, Gunby RH, Redaelli S, Stano P, Carniti C, Bachi A, Tucker PW, Tartari CJ, Huang CJ, Colombo E, Pulford K, Puttini M, Piazza RG, Ruchatz H, Villa A, Donella-Deana A, Marin O, Perrotti D, Gambacorti-Passerini C.
    Blood; 2007 Oct 01; 110(7):2600-9. PubMed ID: 17537995
    [Abstract] [Full Text] [Related]

  • 19. Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo.
    Coluccia AM, Perego S, Cleris L, Gunby RH, Passoni L, Marchesi E, Formelli F, Gambacorti-Passerini C.
    Blood; 2004 Apr 01; 103(7):2787-94. PubMed ID: 14656879
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of Src family protein-tyrosine kinases as a proximal and mandatory step for SYK kinase-dependent phospholipase Cgamma2 activation in lymphoma B cells exposed to low energy electromagnetic fields.
    Dibirdik I, Kristupaitis D, Kurosaki T, Tuel-Ahlgren L, Chu A, Pond D, Tuong D, Luben R, Uckun FM.
    J Biol Chem; 1998 Feb 13; 273(7):4035-9. PubMed ID: 9461594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.